These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30259297)

  • 1. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analyses of refractory testicular germ cell tumors.
    Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
    PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
    Kalavska K; Conteduca V; De Giorgi U; Mego M
    Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
    Cavallo F; Feldman DR; Barchi M
    Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator
    Cardoso IIV; Rosa MN; Moreno DA; Tufi LMB; Ramos LP; Pereira LAB; Silva L; Galvão JMS; Tosi IC; Lengert AVH; Da Cruz MC; Teixeira SA; Reis RM; Lopes LF; Pinto MT
    Mol Med Rep; 2024 Dec; 30(6):. PubMed ID: 39392037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy.
    Singh R; Fazal Z; Bikorimana E; Boyd RI; Yerby C; Tomlin M; Baldwin H; Shokry D; Corbet AK; Shahid K; Hattab A; Freemantle SJ; Spinella MJ
    Mol Oncol; 2022 Feb; 16(3):683-698. PubMed ID: 34482638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
    Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A
    Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of everolimus in refractory testicular germ cell tumors.
    Mego M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Chovanec M; Rejlekova K; Zuzák P; Ondrus D; Spanik S; Reckova M; Mardiak J
    Urol Oncol; 2016 Mar; 34(3):122.e17-22. PubMed ID: 26612480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
    Lobo J; Constâncio V; Leite-Silva P; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
    Clin Epigenetics; 2021 Apr; 13(1):70. PubMed ID: 33823933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will Testicular Germ Cell Tumors Remain Untargetable?
    Aoun F; Kourie HR; Albisinni S; Roumeguère T
    Target Oncol; 2016 Dec; 11(6):711-721. PubMed ID: 27184492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the crosstalk of molecular factors and signaling pathways reveals novel biomarkers of cisplatin resistance in testicular germ cell tumors.
    Roska J; Jurkovicova D
    Neoplasma; 2020 Jan; 67(1):1-14. PubMed ID: 31829026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cell biology of testicular germ cell tumors.
    Chieffi P; Franco R; Portella G
    Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
    Veenstra CM; Vaughn DJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular germ cell tumor: a comprehensive review.
    Batool A; Karimi N; Wu XN; Chen SR; Liu YX
    Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
    Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
    Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
    Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
    Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.